HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effectiveness of INH-rifampicin treatment of lymph node tuberculosis].

Abstract
The efficacy of the therapy of tuberculous lymphadenitis using two drugs with bactericidal activity is described. In this localization, the tuberculous process implies tubercle bacilli only in limited quantity, and thus, in contrast to the requirements and recommendations for the treatment of pulmonary tuberculosis, the application of only two drugs with bactericidal activity is sufficient. The treatment of 128 patients with histologically confirmed tuberculous lymphadenitis consisted in daily application of isoniazid and rifampicin during 4 to 6 weeks, followed by an intermittent treatment with the same drugs for 6 to 9 months. The follow-up period was 7.5 years. Complete involution of the diseased lymph nodes was obtained in two thirds of the patients, partial involution in the remaining third. In one patient, a relapse occurred. The indications of this regimen are discussed.
AuthorsA Weinecke
JournalZeitschrift fur Erkrankungen der Atmungsorgane (Z Erkr Atmungsorgane) Vol. 173 Issue 1 Pg. 63-7 ( 1989) ISSN: 0303-657X [Print] Germany
Vernacular TitleEffektivität der INH-Rifampizin-Behandlung bei Lymphknotentuberkulose.
PMID2800617 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Isoniazid
  • Rifampin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Drug Therapy, Combination
  • Humans
  • Isoniazid (therapeutic use)
  • Middle Aged
  • Rifampin (therapeutic use)
  • Tuberculosis, Lymph Node (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: